Phathom Pharmaceuticals (PHAT) Other Operating Expenses (2019)

Phathom Pharmaceuticals (PHAT) has reported Other Operating Expenses for 1 consecutive years, with $78.9 million the latest figure, recorded in Q2 2019.

• In Q2 2019, Other Operating Expenses changed N/A year-over-year to $78.9 million; the TTM figure through Mar 2020 stood at $78.9 million (changed N/A YoY), while the FY2019 annual figure was $78.9 million, changed N/A from the prior year.
• Other Operating Expenses steadied at $78.9 million in Q2 2019 per PHAT's latest filing.
• Across five years, Other Operating Expenses topped out at $78.9 million in Q2 2019 and bottomed at $78.9 million in Q2 2019.